secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035736
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX borrows additional $1M from Juvenescence, total $12.66M; issues warrants for 847K shares at $0.59
--------------------------------------------------------------------------------

- Borrowed additional $1,000,000 under Secured Convertible Note with Juvenescence. Total outstanding balance now $12,660,000.
- Remaining $500,000 line of credit may be drawn subject to Juvenescence's discretion through first anniversary date.
- In connection with draw, will issue warrants to purchase 847,457 shares of common stock at $0.59 per share.
- Secured Note matures on February 14, 2024; origination fee 4% per draw plus additional 4% after 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/0001493152-22-035736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer